LA Kelley Communications, Inc. Announces the Release of Managing Your Child's Inhibitor, the World’s First Book on Inhibitors.

Share Article

Until now, there has been no book to help parents, patients and families cope with this complication. Managing Your Child’s Inhibitor compiles research, treatment information, and the stories of 40 patients and families to help parents know better what to expect when their child is diagnosed. While written primarily for parents, this book will also be a huge help to medical staff who treat patients with inhibitors.

News Image
"Laurie Kelley has outstanding insight into the challenges of parents of children with hemophilia."

LA Kelley Communications, Inc. announces the release of Managing Your Child's Inhibitor, the world’s first book on inhibitors.

Until now, there has been no book to help parents, patients and families cope with this complication. Managing Your Child’s Inhibitor compiles research, treatment information, and the stories of 40 patients and families to help parents know better what to expect when their child is diagnosed. While written primarily for parents, this book will also be a huge help to medical staff who treat patients with inhibitors.

Written by Laureen A. Kelley with Paul Clement, each of whom have a child with hemophilia, this 279 page book provides everything parents need to know about tackling inhibitors— from risk factors for developing inhibitors, to pain management, to product choices, to ITI and to every day living. No other resource contains as much information as Managing Your Child’s Inhibitor.

"Laurie Kelley has outstanding insight into the challenges of parents of children with hemophilia. In this book, she and colleague Paul Clement focus on the dreaded complication of an inhibitor. They explain the nature of inhibitors and their management in terms that the non-scientist can understand, including cutting-edge treatments that may be available but are not yet licensed. It’s a delight to have another, very useful addition to LA Kelley Communications’ many lay-language books on bleeding disorders." (Carol K. Kasper MD. Emerita Professor of Medicine, University of Southern California Orthopaedic Hospital, Los Angeles, California)

Novo Nordisk Inc., a global provider of diabetes and hemophilia products, provided an unrestricted grant to research, write and publish this book.

You can purchase Managing Your Child's Inhibitor via our website at http://www.kelleycom.com/books.html or by calling 978-352-7657.

About LA Kelley Communications, Inc.
Since 1990, LA Kelley Communications has been a world leader of groundbreaking educational materials and programs on hemophilia and related bleeding disorders. With more than a dozen books, numerous publications, and the oldest hemophilia newsletter in America, LA Kelley Communications remains a trusted source of practical information about raising children with bleeding disorders. The company was founded by Laureen A. Kelley, whose son has hemophilia, is response to the need for practical consumer and parenting information on bleeding disorders. For more information about LA Kelley Communications, Inc, please visit http://www.kelleycom.com or call 978-352-7657.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Laureen Kelley

978-352-7657
Email >
Visit website